Correlation Between Catalyst Pharmaceuticals and Ionis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Ionis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Ionis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Ionis Pharmaceuticals, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Ionis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Ionis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Ionis Pharmaceuticals.
Diversification Opportunities for Catalyst Pharmaceuticals and Ionis Pharmaceuticals
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Catalyst and Ionis is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Ionis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ionis Pharmaceuticals and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Ionis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ionis Pharmaceuticals has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Ionis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Catalyst Pharmaceuticals and Ionis Pharmaceuticals
Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to under-perform the Ionis Pharmaceuticals. In addition to that, Catalyst Pharmaceuticals is 1.59 times more volatile than Ionis Pharmaceuticals. It trades about -0.11 of its total potential returns per unit of risk. Ionis Pharmaceuticals is currently generating about -0.15 per unit of volatility. If you would invest 4,394 in Ionis Pharmaceuticals on January 31, 2024 and sell it today you would lose (195.00) from holding Ionis Pharmaceuticals or give up 4.44% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Catalyst Pharmaceuticals vs. Ionis Pharmaceuticals
Performance |
Timeline |
Catalyst Pharmaceuticals |
Ionis Pharmaceuticals |
Catalyst Pharmaceuticals and Ionis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Catalyst Pharmaceuticals and Ionis Pharmaceuticals
The main advantage of trading using opposite Catalyst Pharmaceuticals and Ionis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Ionis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ionis Pharmaceuticals will offset losses from the drop in Ionis Pharmaceuticals' long position.Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme PharmaInc |
Ionis Pharmaceuticals vs. Arrowhead Pharmaceuticals | Ionis Pharmaceuticals vs. Biomarin Pharmaceutical | Ionis Pharmaceuticals vs. Incyte | Ionis Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |